• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

建立用于表征和区分阿尔茨海默病、轻度认知障碍、额颞叶痴呆和抑郁症患者的可靠认知维度。

Establishing robust cognitive dimensions for characterization and differentiation of patients with Alzheimer's disease, mild cognitive impairment, frontotemporal dementia and depression.

作者信息

Beck Irene R, Schmid Nicole S, Berres Manfred, Monsch Andreas U

机构信息

Memory Clinic, University Center for Medicine of Aging Basel, Felix Platter-Hospital, Basel, Switzerland.

出版信息

Int J Geriatr Psychiatry. 2014 Jun;29(6):624-34. doi: 10.1002/gps.4045. Epub 2013 Nov 14.

DOI:10.1002/gps.4045
PMID:24227657
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4265200/
Abstract

OBJECTIVE

The diagnosis of mild cognitive impairment (MCI) and dementia requires detailed neuropsychological examinations. These examinations typically yield a large number of outcome variables, which may complicate the interpretation and communication of results. The purposes of this study were the following: (i) to reduce a large data set of interrelated neuropsychological variables to a smaller number of cognitive dimensions; (ii) to create a common metric for these dimensions (z-scores); and (iii) to study the ability of the cognitive dimensions to distinguish between groups of patients with different types of cognitive impairment.

METHODS

We tested 1646 patients with different forms of dementia or with a major depression with a standard (n = 632) or, if cognitively less affected, a challenging neuropsychological battery (n = 1014). To identify the underlying cognitive dimensions of the two test batteries, maximum likelihood factor analyses with a promax rotation were conducted. To interpret the sum scores of the factors as standard scores, we divided them by the standard deviation of a cognitively healthy sample (n = 1145).

RESULTS

The factor analyses yielded seven factors for each test battery. The cognitive dimensions in both test batteries distinguished patients with different forms of dementia (MCI, Alzheimer's dementia or frontotemporal dementia) and patients with major depression. Furthermore, patients with stable MCI could be separated from patients with progressing MCI. Discriminant analyses with an independent new sample of patients (n = 306) revealed that the new dimension scores distinguished new samples of patients with MCI from patients with Alzheimer's dementia with high accuracy.

CONCLUSION

These findings suggest that these cognitive dimensions may benefit neuropsychological diagnostics.

摘要

目的

轻度认知障碍(MCI)和痴呆的诊断需要详细的神经心理学检查。这些检查通常会产生大量的结果变量,这可能会使结果的解释和交流变得复杂。本研究的目的如下:(i)将大量相互关联的神经心理学变量数据集简化为较少数量的认知维度;(ii)为这些维度创建一个通用指标(z分数);(iii)研究认知维度区分不同类型认知障碍患者组的能力。

方法

我们用标准神经心理学测试组(n = 632)或在认知影响较轻时用具有挑战性的神经心理学测试组(n = 1014)对1646例患有不同形式痴呆或重度抑郁症的患者进行了测试。为了确定两个测试组潜在的认知维度,我们进行了采用斜交旋转的极大似然因子分析。为了将因子的总分解释为标准分数,我们将它们除以认知健康样本(n = 1145)的标准差。

结果

每个测试组的因子分析都产生了七个因子。两个测试组中的认知维度能够区分不同形式痴呆(MCI、阿尔茨海默病性痴呆或额颞叶痴呆)患者和重度抑郁症患者。此外,稳定型MCI患者与进展型MCI患者也能够被区分开来。对一个独立的新患者样本(n = 306)进行的判别分析表明,新的维度分数能够高精度地区分MCI患者新样本与阿尔茨海默病性痴呆患者新样本。

结论

这些发现表明,这些认知维度可能对神经心理学诊断有益。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b474/4265200/74e053a06d96/gps0029-0624-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b474/4265200/74e053a06d96/gps0029-0624-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b474/4265200/74e053a06d96/gps0029-0624-f1.jpg

相似文献

1
Establishing robust cognitive dimensions for characterization and differentiation of patients with Alzheimer's disease, mild cognitive impairment, frontotemporal dementia and depression.建立用于表征和区分阿尔茨海默病、轻度认知障碍、额颞叶痴呆和抑郁症患者的可靠认知维度。
Int J Geriatr Psychiatry. 2014 Jun;29(6):624-34. doi: 10.1002/gps.4045. Epub 2013 Nov 14.
2
Improved Accuracy of the Addenbrooke's Cognitive Examination-Revised in the Diagnosis of Mild Cognitive Impairment, Mild Dementia Due to Alzheimer's Disease and Behavioral Variant Frontotemporal Dementia Using Mokken Scale Analysis.基于莫克尺度分析的改良爱丁堡认知评估量表修订版在轻度认知障碍、阿尔茨海默病所致轻度痴呆和行为变异型额颞叶痴呆诊断中的准确性提高。
J Alzheimers Dis. 2024;100(s1):S45-S55. doi: 10.3233/JAD-240554.
3
The Tree-Drawing Test (Koch's Baum Test): A Useful Aid to Diagnose Cognitive Impairment.树形图测试(科赫树形测试):诊断认知障碍的有用辅助手段。
Behav Neurol. 2015;2015:534681. doi: 10.1155/2015/534681. Epub 2015 Jun 15.
4
Depressive symptoms influence global cognitive impairment indirectly by reducing memory and executive function in patients with mild cognitive impairment.抑郁症状通过降低轻度认知障碍患者的记忆和执行功能,间接地影响其整体认知障碍。
J Neurol Neurosurg Psychiatry. 2016 Dec;87(12):1375-1383. doi: 10.1136/jnnp-2016-314191. Epub 2016 Oct 19.
5
Estimating Alzheimer's Disease Progression Rates from Normal Cognition Through Mild Cognitive Impairment and Stages of Dementia.从正常认知到轻度认知障碍及痴呆阶段估算阿尔茨海默病的进展速度。
Curr Alzheimer Res. 2018;15(8):777-788. doi: 10.2174/1567205015666180119092427.
6
Combined Socio-Behavioral Evaluation Improves the Differential Diagnosis Between the Behavioral Variant of Frontotemporal Dementia and Alzheimer's Disease: In Search of Neuropsychological Markers.联合社会行为评估可提高行为变异型额颞叶痴呆与阿尔茨海默病的鉴别诊断:寻找神经心理学标志物。
J Alzheimers Dis. 2018;61(2):761-772. doi: 10.3233/JAD-170650.
7
The Head Turning Sign in Dementia and Mild Cognitive Impairment: Its Relationship to Cognition, Behavior, and Cerebrospinal Fluid Biomarkers.痴呆和轻度认知障碍中的转头征:与认知、行为和脑脊液生物标志物的关系。
Dement Geriatr Cogn Disord. 2018;46(1-2):42-49. doi: 10.1159/000486531. Epub 2018 Aug 9.
8
Diagnostic value of digital clock drawing test in comparison with CERAD neuropsychological battery total score for discrimination of patients in the early course of Alzheimer's disease from healthy individuals.数字时钟绘画测试与 CERAD 神经心理学成套测验总分在鉴别阿尔茨海默病早期患者与健康个体中的诊断价值比较。
Sci Rep. 2019 Mar 5;9(1):3543. doi: 10.1038/s41598-019-40010-0.
9
Neuropsychological Profiles, Etiologies, and Medical Comorbidities in Early-Onset Dementia and Cognitive Impairment: A Memory Outpatient Clinic Cohort Study.早期发病的痴呆和认知障碍的神经心理学特征、病因和合并的医学疾病:记忆门诊队列研究。
J Alzheimers Dis. 2024;97(4):1765-1776. doi: 10.3233/JAD-230877.
10
Can cognitive assessment really discriminate early stages of Alzheimer's and behavioural variant frontotemporal dementia at initial clinical presentation?在初始临床表现时,认知评估真的能够区分阿尔茨海默病和行为变异型额颞叶痴呆的早期阶段吗?
Alzheimers Res Ther. 2017 Aug 9;9(1):61. doi: 10.1186/s13195-017-0287-1.

引用本文的文献

1
[An arachnoid cyst mimicking a symptomatic Alzheimer's disease].[一例酷似有症状阿尔茨海默病的蛛网膜囊肿]
Nervenarzt. 2024 Jun;95(6):560-563. doi: 10.1007/s00115-024-01638-0. Epub 2024 Mar 14.
2
White matter hyperintensities associated with small vessel disease impair social cognition beside attention and memory.与小血管病相关的脑白质高信号除了损害注意力和记忆力外,还会损害社会认知。
J Cereb Blood Flow Metab. 2018 Jun;38(6):996-1009. doi: 10.1177/0271678X17719380. Epub 2017 Jul 7.
3
Microstate connectivity alterations in patients with early Alzheimer's disease.

本文引用的文献

1
The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease.阿尔茨海默病所致痴呆的诊断:美国国家老龄化研究所-阿尔茨海默病协会工作组关于阿尔茨海默病诊断指南的建议。
Alzheimers Dement. 2011 May;7(3):263-9. doi: 10.1016/j.jalz.2011.03.005. Epub 2011 Apr 21.
2
The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease.阿尔茨海默病所致轻度认知障碍的诊断:美国国家老龄化研究所-阿尔茨海默病协会诊断指南工作组的建议。
Alzheimers Dement. 2011 May;7(3):270-9. doi: 10.1016/j.jalz.2011.03.008. Epub 2011 Apr 21.
3
早期阿尔茨海默病患者的微状态连接改变
Alzheimers Res Ther. 2015 Dec 31;7:78. doi: 10.1186/s13195-015-0163-9.
4
The 12 Years Preceding Mild Cognitive Impairment Due to Alzheimer's Disease: The Temporal Emergence of Cognitive Decline.阿尔茨海默病所致轻度认知障碍之前的12年:认知衰退的时间性显现
J Alzheimers Dis. 2015;48(4):1095-107. doi: 10.3233/JAD-150137.
5
Gains in cognition through combined cognitive and physical training: the role of training dosage and severity of neurocognitive disorder.通过认知与身体综合训练实现的认知能力提升:训练剂量及神经认知障碍严重程度的作用
Front Aging Neurosci. 2015 Aug 7;7:152. doi: 10.3389/fnagi.2015.00152. eCollection 2015.
6
A new delirium phenotype with rapid high amplitude onset and nearly as rapid reversal: Central Coast Australia Delirium Intervention Study.一种具有快速高幅度发作且几乎同样快速逆转的新型谵妄表型:澳大利亚中部海岸谵妄干预研究。
Clin Interv Aging. 2015 Feb 13;10:473-80. doi: 10.2147/CIA.S78206. eCollection 2015.
7
Depressive symptoms are associated with analgesic use in people with Alzheimer's disease: Kuopio ALSOVA study.抑郁症状与阿尔茨海默病患者的镇痛药使用有关:库奥皮奥ALSOVA研究。
PLoS One. 2015 Feb 17;10(2):e0117926. doi: 10.1371/journal.pone.0117926. eCollection 2015.
8
Considering the base rates of low performance in cognitively healthy older adults improves the accuracy to identify neurocognitive impairment with the Consortium to Establish a Registry for Alzheimer's Disease-Neuropsychological Assessment Battery (CERAD-NAB).考虑到认知健康的老年人中低表现的基础比率,可提高使用阿尔茨海默病神经心理学评估量表注册库联盟(CERAD-NAB)识别神经认知障碍的准确性。
Eur Arch Psychiatry Clin Neurosci. 2015 Aug;265(5):407-17. doi: 10.1007/s00406-014-0571-z. Epub 2015 Jan 3.
Latent structure and factorial invariance of a neuropsychological test battery for the study of preclinical Alzheimer's disease.用于研究临床前阿尔茨海默病的神经心理学测试组合的潜在结构和因子不变性。
Neuropsychology. 2010 Nov;24(6):742-756. doi: 10.1037/a0020176.
4
Cognitive Dimensions in Alzheimer's Disease, Mild Cognitive Impairment, and Normal Elderly: Developing a Common Metric.阿尔茨海默病、轻度认知障碍和正常老年人的认知维度:建立通用指标。
Open Geriatr Med J. 2010 Jan 28;3(10):1-10. doi: 10.2174/1874827901003010001.
5
Early detection of Alzheimer's disease with a total score of the German CERAD.使用德国 CERAD 的总分进行阿尔茨海默病的早期检测。
J Int Neuropsychol Soc. 2010 Sep;16(5):910-20. doi: 10.1017/S1355617710000822. Epub 2010 Aug 4.
6
Diagnosis of Alzheimer's disease using neuropsychological testing improved by multivariate analyses.使用神经心理学测试并结合多元分析可提高阿尔茨海默病的诊断率。
J Clin Exp Neuropsychol. 2010 Oct;32(8):793-808. doi: 10.1080/13803390903540315.
7
Long-term follow-up of patients immunized with AN1792: reduced functional decline in antibody responders.接受AN1792免疫接种患者的长期随访:抗体应答者功能衰退减缓
Curr Alzheimer Res. 2009 Apr;6(2):144-51. doi: 10.2174/156720509787602852.
8
Safety, efficacy, and biomarker findings of PBT2 in targeting Abeta as a modifying therapy for Alzheimer's disease: a phase IIa, double-blind, randomised, placebo-controlled trial.PBT2靶向β淀粉样蛋白作为阿尔茨海默病修饰疗法的安全性、有效性及生物标志物研究结果:一项IIa期、双盲、随机、安慰剂对照试验
Lancet Neurol. 2008 Sep;7(9):779-86. doi: 10.1016/S1474-4422(08)70167-4. Epub 2008 Jul 30.
9
Exploring the structure of a neuropsychological battery across healthy elders and those with questionable dementia and Alzheimer's disease.探索针对健康老年人以及有可疑痴呆症和阿尔茨海默病患者的神经心理成套测验的结构。
Neuropsychology. 2008 May;22(3):400-11. doi: 10.1037/0894-4105.22.3.400.
10
Cognitive-behavioral profiles of neurodegenerative dementias: beyond Alzheimer's disease.神经退行性痴呆的认知行为特征:超越阿尔茨海默病
J Geriatr Psychiatry Neurol. 2007 Dec;20(4):227-38. doi: 10.1177/0891988707308806.